Stopping weight loss drugs linked to weight regain and reversal of heart health markers
Peer-Reviewed Publication
In recognition of Heart Health Month, we’re spotlighting the importance of cardiovascular wellness. From risk factors and prevention to innovative treatments, we’re exploring the science and stories shaping heart health today.
Updates every hour. Last Updated: 10-Jun-2026 06:15 ET (10-Jun-2026 10:15 GMT/UTC)
The National Institutes of Health has awarded the Icahn School of Medicine at Mount Sinai an $8.5 million renewal grant to continue groundbreaking work aimed at understanding and improving long-term outcomes for children with congenital heart disease—the most common type of birth defect in the United States.
A study led by Maria Carmo-Fonseca at the GIMM Foundation has helped clarify one of the main limitations of lab-grown heart cells, which are widely used around the world to study heart disease and test new drugs. Although these cells make it possible to investigate the human heart without invasive procedures or animal models, they still fail to fully reproduce the characteristics of real heart cells, which can compromise the accuracy of certain studies.
In a world-first, a team of researchers at the National Institutes of Health (NIH) and Emory School of Medicine, Atlanta, has successfully performed a coronary artery bypass — a normally open-heart surgery — without cutting the chest wall. The team employed a novel intervention to prevent the blockage of a vital coronary artery, which is a very rare but often lethal complication following a heart-valve replacement. The results suggest that, in the future, a less traumatic alternative to open-heart surgery could become widely available for those at risk of coronary artery obstruction.